The effect of single administration of vascular endothelial growth factor or L-arginine on necrosis and vasculature of the epigastric flap in the rat model

British Journal of Plastic Surgery

Volumn 57, Issue 4, 2004, Pages 317-325

  Komorowska Timek, Ewa ^a,b   Timek, Tomasz A ^b   Brevetti, Lucy S ^c   Zhang, Feng ^d   Lineaweaver, Wiliiam C ^d   Buncke, Harry J ^a  

^a Buncke Clinic   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Animal study; Flap necrosis; L arginine; VEGF

Indexed keywords

ARGININE; MICROSPHERE; NITRIC OXIDE; SODIUM CHLORIDE; VASCULOTROPIN;

ANALYSIS OF VARIANCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CATHETERIZATION; ARTERY LIGATION; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG EFFICACY; FLUORESCENCE; INFERIOR EPIGASTRIC ARTERY; NONHUMAN; PERFUSION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; RAT STRAIN; SINGLE DRUG DOSE; SKIN FLAP; SURGICAL TECHNIQUE; SUTURE; TISSUE FLAP; TISSUE NECROSIS; VASCULARIZATION; VASODILATATION;

EID: 2942615369     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2003.12.036     Document Type: Article

References (45)

1. Pu LL, Ahmed S, Thomson JG, Reid MA, Madsen JA, Restifo RJ. Endothelial cell growth factor enhances musculocutaneous flap survival through the process of neovascularization. Ann Plast Surg 1999;42:306-12.
2. Kryger Z, Zhang F, Dogan T, Cheng C, Lineaweaver WC, Buncke HJ. The effects of VEGF on survival of a random flap in the rat: examination of various routs of administration. Br J Plast Surg 2000;53:234-9.
3. Kryger Z, Dogan T, Zhang F, Komorowska-Timek E, Shi DY, Cheng C. Effect of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 1999;43:172-8.
4. Erçöçen AR, Apaydin I, Emirľu M, Gültan SM, Ergün H, Yormuk E. The effects of L-arginine and iloprost on the viability of random skin flaps in rats. Scand J Plast Reconstr Hand Surg 1998;32:19-25.
5. Um SC, Suzuki S, Shinya T, Byung MK, Tanaka T, Hiai. Involvment of nitric oxide in survival of random pattern skin flap. Plast Reconstr Surg 1998;101:785-92.
6. O'Toole G, MacKenzie D, Buckley MF, Lindeman R, Poole M. A review of therapeutic angiogenesis and consideration of its potential applications to plastic and reconstructive surgery. Br J Plast Surg 2001;54:1-7.
7. Padubidri A, Browne E. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flap in the rat. Ann Plast Surg 1996;37:604-11.
8. Hom DB, Assefa G. Effects of endothelial cell growth factor on vascular compromised skin flaps. Arch Otolaryngol Head Neck Surg 1992;118:624-8.
9. Stepnick DW, Peterson MK, Bodgan C, Davis J, Wasman J, Mailer K. Effects of tumor necrosis factor a and vascular permeability factor on neovascuiarization of the rabbit ear flap. Arch Otolaryngol Head Neck Surg 1995;121:667-72.
10. Banbury J, Siemionow M, Porvasnik S, Petras S, Browne E. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor. Plast Reconstr Surg 2000;106:1541-6.
11. Bauters C, Takayuki A, Zheng LP, Takeshita S, Bunting S, Ferrara N, et al. Recovery of disturbed endothelium-dependent flow in the collateral-perf used rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 1995;91:2802-9.
12. Takeshita S, Pu LQ, Stein LA, Sniderman AD, Bunting S, Ferrara N, et al. Intramuscular administration of vascular endothelial growth factor induced dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994;90(II):228-34.
13. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, et al. Nitric oxide synthase ties downstream from vascular endothetial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997;99:2625-34.
14. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 1998;101: 2567-78.
15. Papapetropoulos; A, Garcia-Cardeña G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothetial cells. J Ctin Invest 1997;100:3131-9.
16. Dulak J, Józkowicz A, Dembinska-Kieć A, Guevara I, Zdzienicka A, Zmudzinska-Grochot D, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:659-66.
17. Matsunaga T, Warltier DC, Weihrauch DW, Moniz M, Tessmer J, Chilian WM. Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide. Circulation 2000;102:3098-103.
18. Parenti A, Morbidelli L, Cui XL. Ntric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 1998;273:4220-6.
19. Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001;73:673-86.
20. Maxwell AJ, Cooke JP. Cardiovascular effects of L-arginine. Curr Opin Nephrol Hypertens 1998;7:63-70.
21. Knox LK, Stewart AG, Hayward PG, Morrison WA. Nitric oxide synthase inhibitors improve skin flap survival in the rat. Microsurgery 1994;15:708-11.
22. Eppler SM, Combs DL, Henry TD, Lopez JJ, Ellis SG, Yi JH, et al. A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther 2002;72:20-32.
23. Yang R, Bunting S, Ko A, Keyt BA, Modi NB, Zioncheck TF, et al. Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J Pharmacol Exper Ther 1998;284:103-10.
24. 165 in a pig model of chronic myocardial ischemia. J Am Coll Cardiol 2001;37: 616-23.
25. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25.
26. Isner JM. Tissue responses to ischemia: local and remote responses for preserving perfusion of ischemic muscle. J Clin Invest 2000;106:615-9.
27. Padubidri AN, Browne Jr. E. Modification in flap design of the epigastric artery flap in rats-a new experimental flap model. Ann Plast Surg 1997;39:500-4.
28. Komorowska-Timek E, Newlin L, Zhang F. Dogan T, Lineaweaver WC, Buncke HJ. Shortening of rat teeth prevents autocannibalization of surgical flaps. J Reconstr Microsurg 1999;15:303-6.
29. Finseth F, Adelberg MG. Prevention of skin flap necrosis by a course of treatment with vasodilator drugs. Plast Reconstr Surg 1978;61:738-43.
30. Finseth F, Cutting C. An experimental neurovascular island skin flap for the study of the delay phenomenon. Plast Reconstr Surg 1978;61:412-20.
31. Deveci D, Egginton S. Development of the fluorescent microsphere technique for quantifying regional blood flow in small mammals. Exp Physiol 1999;84:615-30.
32. Zhang F, Richards L. Angel MF, Zhang J, Liu H, Dorsett-Martin W, et al. Accelerating flap maturation by vascular endothelium growth factor in a rat tube flap model. Br J Plast Surg 2002;55:59-63.
33. Lubiatowski P, Goldman CK, Gurunluoglu R, Carnevale K, Siemionow M. Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 2002;109:1986-93.
34. Taub PJ, Marmur JD, Zhang WX, Senderoff D, Nhat PD, Phelps R, et al. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps. Plast Reconstr Surg 1998;102:2033-9.
35. Lovett JE, Fink BF, Bernard A, Ochoa J. Analysis of nitric oxide activity of reperfusion injury. Ann Plost Surg 2001;46: 269-74.
36. Phan LH, Hickey MJ, Niazi ZB, Steward AG. Nitric oxide synthase inhibitor, nitro-iminoethyl-L-ornithine, reduces ischemia-reperfusion injury in rabbit skeletal muscle. Microsurgery 1994; 15:703-7.
37. Cordiero PG, Mastorakos; DP, Hu QY, Kirschner RE. The protective effect of L-arginine on ischemia-reperfusion injury in rat skin flaps. Plast Reconstr Surg 1997;100: 1227-33.
38. Cordeiro PG, Santamaria E, Hu QY. Use of a nitric oxide precursor to protect pig myocutaneous flaps from ischemia-reperfusion injury. Plast Reconstr Surg 1998;102:2040-51.
39. Bayramiçli M, Yilmaz B, Numanoǧlu A. Contraction of experimental flaps. Ann Plast Surg 1998;41:185-90.
40. Bode-Böger SM, Böger RH, Alfke H, Heinzel D, Tsikas D, Creutzig, et al. L-arginine induces nitric oxide-dependent vasodilatation in patients with critical limb ischemia. A randomized, controlled study. Circulation 1996;93:85-90.
41. Lubiatowski P, Gurunluoglu R, Goldman CK, Skugor B, Carnevale K, Siemionow M. Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast Reconstr Surg 2002;110:149-59.
42. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995;92(Suppl. II):365-71.
43. Dafni H, Landsman L, Schechter B, Kohen F, Neeman M. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Warned 2002; 15:120-31.
44. Taylor GI, Palmer JH. The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg 1987;40:113-41.
45. Kane AJ, Barker JE, Mitchell GM, Theile DR, Romero R, Messina A, et al. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol 2002;132:1631-8.